Form 4: CEO Sells ALHC Shares for Tax Obligations

Alignment Healthcare CEO John E. Kao sold 73,046 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• John E. Kao, Chief Executive Officer and Director of Alignment Healthcare, Inc. (ALHC), reported a sale of 73,046 shares of common stock.
• The transaction occurred on March 18, 2026, at a weighted-average price of $17.84 per share, with prices ranging from $17.40 to $18.24.
• The sale was explicitly stated to cover tax withholding obligations in connection with the vesting of restricted stock units and does not represent a discretionary trade.
• Following the transaction, Mr. Kao directly beneficially owns 1,784,868 shares of common stock.
• Additionally, Mr. Kao indirectly beneficially owns 2,472,641 shares through the JEK Trust, dated February 8, 2021, for which he serves as trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax purposes, a common occurrence with RSU vesting, and does not reflect a change in company fundamentals or management confidence.

Positives

• The sale was non-discretionary, solely for tax withholding purposes related to RSU vesting, which is a routine event and typically not a signal of a lack of confidence by management.

Negatives

• A reduction in direct beneficial ownership by a key executive, even if for tax purposes, slightly decreases management's direct equity stake.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The reported transaction does not represent a discretionary trade by the reporting person, but rather shares required to be sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that tax-related sales by executives are a common and expected occurrence when restricted stock units vest. Such transactions typically do not signal a change in management's outlook on the company's prospects, unlike discretionary sales, and are generally viewed as a neutral event within the broader healthcare technology sector.

Comparison to Industry Standards

• Sales of shares by executives to cover tax withholding obligations upon the vesting of restricted stock units are a common and standard practice across publicly traded companies, including peers in the healthcare technology sector such as Teladoc Health (TDOC) or Amwell (AMWL).
• This type of transaction is generally not indicative of a change in management's long-term outlook, unlike discretionary sales, and aligns with standard executive compensation practices.

Related Party Transactions

• John E. Kao's indirect beneficial ownership of 2,472,641 shares is held by the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. This structure is disclosed as part of his beneficial ownership.

Stakeholder Impact

• Shareholders: Minimal impact as the sale is non-discretionary and for tax purposes, not signaling a change in company outlook. The volume represents a small fraction of total outstanding shares.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The transaction is a non-discretionary sale to cover tax obligations from restricted stock unit vesting, which is a routine event and does not reflect a change in the company's fundamentals or management's confidence. Therefore, it does not warrant a change in investment recommendation.

Keywords

Alignment Healthcare, ALHC, John E. Kao, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO